Month: October 2013

Allopartis Acquired By Novozymes

October 10, 2013

In XSeed’s first fund, we allocated a portion of capital to entrepreneurs pursuing breakthrough innovation at the intersection of IT and other technical disciplines. Our reasoning in pursuing these and a handful of other such investments was straight- forward: We believed, given the cost-performance vector of IT, that it would rapidly transform other disciplines and that companies could be

Read More